Facebook
Instagram
Linkedin
RSS
Telegram
Tumblr
X
Website
Youtube
Sign in
Join
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Middle East Business News and Information – mid-east.info
Home
Submit a press release
Partner Events
Partner with us
About us
Terms of use
Privacy policy
Contact us
Home
Pharmaceuticals
Hikma Pharmaceuticals
Hikma Pharmaceuticals
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Hikma acquires the rights to a portfolio of Takeda brands for the MENA region
December 20, 2024
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa region
Good momentum across all businesses and updated Generics guidance
Hikma continues strong 2020 performance and updates full year guidance
Hikma strengthens US Injectables business through acquisition of Custopharm
Hikma Ventures leads seed financing round for Egypt based O7 Therapy;...
April 4, 2022
Hikma expands licensing agreement with Celltrion for Remsima® subcutaneous formulation in...
February 9, 2022
Hikma Pharmaceuticals and Sesen Bio announce exclusive partnership to commercialise Vicineum™...
December 1, 2020
Hikma delivers another strong financial and operational performance, and improves FY...
August 8, 2021
Hikma continues strong strategic execution and reiterates guidance
November 7, 2024
Hikma delivers another year of profitable growth in 2021 and announces...
February 27, 2022
Hikma acquires the rights to a portfolio of Takeda brands for...
December 20, 2024
Hikma delivers strong H1 preformance and raises Generics guidance
August 3, 2023
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma®...
January 4, 2023
Hikma’s diversified business delivers resilient H1 performance
August 4, 2022
1
2
Page 1 of 2
Connect with us
1,858
Fans
Like
367
Followers
Follow
1,929
Followers
Follow
30
Subscribers
Subscribe
